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Abstract During metabolic acidosis (MA), urinary phos-
phate excretion increases and contributes to acid removal.
Two Na+-dependent phosphate transporters, NaPi-IIa
(Slc34a1) and NaPi-IIc (Slc34a3), are located in the brush
border membrane (BBM) of the proximal tubule and mediate
renal phosphate reabsorption. Transcriptome analysis of
kidneys from acid-loaded mice revealed a large decrease in
NaPi-IIc messenger RNA (mRNA) and a smaller reduction
in NaPi-IIa mRNA abundance. To investigate the contribu-
tion of transporter regulation to phosphaturia during MA, we
examined renal phosphate transporters in normal and
Slc34a1-gene ablated (NaPi-IIa KO) mice acid-loaded for 2
and 7 days. In normal mice, urinary phosphate excretion was
transiently increased after 2 days of acid loading, whereas no
change was found in Slc34a1−/− mice. BBM Na/Pi
cotransport activity was progressively and significantly
decreased in acid-loaded KO mice, whereas in WT animals,
a small increase after 2 days of treatment was seen. Acidosis
increased BBM NaPi-IIa abundance in WT mice and NaPi-
IIc abundance in WT and KO animals. mRNA abundance of
NaPi-IIa and NaPi-IIc decreased during MA. Immunohisto-
chemistry did not indicate any change in the localization of
NaPi-IIa and NaPi-IIc along the nephron. Interestingly,
mRNA abundance of both Slc20 phosphate transporters,
Pit1 and Pit2, was elevated after 7 days of MA in normal and
KO mice. These data demonstrate that phosphaturia during
acidosis is not caused by reduced protein expression of the
major Na/Pi cotransporters NaPi-IIa and NaPi-IIc and
suggest a direct inhibitory effect of low pH mainly on
NaPi-IIa. Our data also suggest that Pit1 and Pit2 trans-
porters may play a compensatory role.
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Introduction
Body inorganic phosphate (Pi) homeostasis is the product of
intestinal absorption and renal excretion or reabsorption,
respectively. The bulk of filtered phosphate is reabsorbed at
the brush border membrane (BBM) of proximal tubular cells
via action of sodium-dependent phosphate (Na/Pi) trans-
porters, NaPi-IIa (Slc34a1) [23], and to a smaller extent,
NaPi-IIc (Slc34a3) [30]. Abundance and activity of NaPi-IIa
are regulated by a variety factors, including dietary Pi intake,
parathyroid hormone, as well as other hormones [18, 22, 24],
and FGF23 [21]. In contrast, less is known about the
regulation of NaPi-IIc, which appears to be modulated by
dietary phosphate intake, growth, and FGF-23 [26, 30–32].
Intestinal Pi absorption appears to be mediated by one
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sodium-dependent cotransporter NaPi-IIb (Slc34a2) that may
be also altered by dietary Pi intake, 1,25 (OH)2-dihydroxy-
vitamin D3, and FGF-23 [8, 14, 28].
Recently, a different class (type III) of Na+-dependent Pi
transporters were identified in rat kidney: Pit1 (Glvr-1,
Slc20a1) and Pit2 (Ram-1, Slc20a2) [15, 16]. Both Pit1 and
Pit2 are widely distributed in many tissues, suggesting that
they serve as housekeeping Na/Pi cotransporters in mam-
malian cells [15].The exact cellular and subcellular local-
ization of Pit1 and Pit2 in the kidney remains to be
determined, although in situ hybridization suggests expres-
sion along the proximal nephron [35].
The bulk of apical Na/Pi cotransport activity in the proximal
tubule is accounted for by the type IIa Na/Pi cotransporter, as
evident from murine NaPi-IIa gene ablation studies [3]. NaPi-
IIc has been suggested to be growth-related and important
only during weaning in rodents [30]. However, recent studies
identified SLC34A3 mutations in patients with hereditary
hypophosphatemic rickets with hypercalciuria, indicating that
NaPi-IIc may play a more prominent role in maintaining
body phosphate homeostasis than previously thought [4, 19].
During metabolic acidosis, phosphate is released from
bone together with Ca2+ and carbonate [17] and is excreted
into urine in large amounts [12]. Phosphate, together with
ammonia and citrate, acts as so-called titratable acid that
binds protons and increases the kidney’s ability to excrete
protons. Ambuhl et al. reported previously that induction of
metabolic acidosis in a rat model caused massive down-
regulation of sodium-dependent phosphate transport activ-
ity in brush border membrane vesicles associated with
reduced NaPi-IIa messenger RNA (mRNA) and protein
abundance [1]. In contrast, we failed to find a clear
reduction in brush border membrane Na+/phosphate co-
transport activity and NaPi-IIa expression both in rat and
mouse kidney despite massive phosphaturia [33].
During complementary DNA (cDNA) microarray screen-
ing of mouse kidneys 2 and 7 days after the induction of
metabolic acidosis, we found strong downregulation of NaPi-
IIc mRNA abundance, which may contribute to the phospha-
turia observed [25]. To further investigate the contribution of
phosphate transporter regulation to phosphaturia, we induced
metabolic acidosis for 2 and 7 days in C57BL/6 and NaPi-IIa
KO mice and examined NaPi-IIa, NaPi-IIc, Pit1, and Pit2
mRNA expression, changes in NaPi-IIa and NaPi-IIc protein
abundance, transport activity, and cotransporter localization.
Materials and methods
Animals
All experiments were performed on 12-week-old C57BL/6J
and homozygous NaPi-IIa-deficient (Slc34a1−/−) male mice.
The generation, breeding, and genotyping of these mice have
been described previously [3]. All experiments were
performed according to Swiss Animal Welfare laws and
approved by the local veterinary authority (Veterinäramt
Zürich).
Metabolic studies
To induce metabolic acidosis, male C57BL/6J and NaPi-IIa
deficient mice were given 0.28 M NH4Cl/ 2% sucrose in
drinking water for 2 or 7 days. The control group received
only 2% sucrose in drinking water for 7 days. Each group
consisted of five animals for each time point, treatment, and
genotype. Forty-eight hours prior to sacrifice, mice were
housed in metabolic cages (single mouse metabolic cages,
Tecniplast, Buguggiate, Italy) and had free access to
standard mouse chow and drinking water ad libitum. Daily
chow (standard rodent chow GLP3433, Kliba AG, Switzer-
land: 0.8 % phosphate, 1.05 % calcium, 0.2 % magnesium),
water intake, and body weights were measured, and urine
was collected under mineral oil. For the acute induction of
metabolic acidosis, mice were trained over 5 days to receive
food only for 6 h in the morning. Two days before the
actual experiment, mice were adapted to metabolic cages.
On the day of the experiment, mice received either standard
chow or 2 g NH4Cl/100g standard chow over a period of
6 h with free access to water. Urine was collected over 6h.
Before and after the collection period, urinary bladders
were emptied by abdominal massage. At the end of all
metabolic cage experiments, mice were anesthetized with
ketamine–xylazine, and heparinized mixed arterial-venous
blood was collected and analyzed immediately for pH,
blood gases, and electrolytes on a Radiometer ABL 800
(Radiometer, Copenhagen, Denmark) blood gas analyzer.
Plasma was collected and frozen until further analysis. Both
kidneys were harvested and rapidly frozen in liquid
nitrogen and stored at −80°C.
Urinary pH was measured using a pH microelectrode
(691 pH-meter, Metroholm). Urinary creatinine was mea-
sured by the Jaffe method [29]. Ammonium in urine was
measured by the method of Berthelot [5]. Urine and
plasma phosphate were measured using a commercial kit
(Sigma Diagnostics, Munich, Germany). Urinary electro-
lytes (Na+, K+, Ca2+, Mg2+, Cl−) were measured by ion
chromatography (Metrohm ion chromatograph, Herisau,
Switzerland).
RNA extraction and reverse transcription
Snap-frozen kidneys (five kidneys for each condition) were
homogenized in RLT-Buffer (Qiagen, Basel, Switzerland)
supplemented with β-mercaptoethanol to a final concentra-
tion of 1%. Total RNA was extracted from 200 μl aliquots
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of each homogenized sample using the RNeasy Mini Kit
(Qiagen) according to the manufacturer’s instructions.
Quality and concentration of the isolated RNA preparations
were analyzed by the ND-1000 spectrophotometer (Nano-
Drop Technologies). Total RNA samples were stored at
−80°C. Each RNA sample was diluted to 100 ng/μl and
3 μl used as a template for reverse transcription using the
TaqMan Reverse Transcription Kit (Applied Biosystems,
Forster City, CA, USA). For reverse transcription, 300 ng
of RNA template were diluted in a 40-μl reaction mix that
contained (final concentrations) RT buffer (1×), MgCl2
(5.5mM), random hexamers (2.5 μM), RNase inhibitor
(0.4U/μl), the multiscribe reverse transcriptase enzyme
(1.25U/μl), dNTP mix (500 μM each), and RNase-free
water.
Real-time quantitative PCR
Quantitative real-time qRT-PCR was performed on the ABI
PRISM 7700 Sequence Detection System (Applied Bio-
systems). Primers for all genes of interest (Table 1) were
designed using Primer Express software from Applied
Biosystems. Primers were chosen to result in amplicons
no longer than 150bp spanning intron-exon boundaries to
exclude genomic DNA contamination. The specificity of all
primers was first tested on mRNA derived from kidney and
always resulted in a single product of the expected size
(data not shown). Probes were labeled with the reporter dye
FAM at the 5’ end and the quencher dye TAMRA at the 3’
end (Microsynth, Balgach, Switzerland). Real-Time PCR
reactions were performed using TaqMan Universal PCR
Master Mix (Applied Biosystems). Briefly, 3.5 μl cDNA,
1 μl of each primer (25 μM), 0.5 μl labeled probe (5 μM),
6.5 μl RNAse-free water, and 12.5 μl TaqMan Universal
PCR Master Mix reached 25 μl of final reaction volume.
Reaction conditions were denaturation at 95°C for 10 min
followed by 40 cycles of denaturation at 95°C for 15s and
annealing/elongation at 60°C for 60s with auto ramp time.
All reactions were run in duplicate. For analyzing the data,
the threshold was set to 0.06 as this value had been determined
to be in the linear range of the amplification curves for all
mRNAs in all experimental runs. The expression of gene of
interest was calculated in relation to hypoxanthine guanine
phosphoribosyl transferase (HPRT). Relative expression
ratios were calculated as R = 2(Ct(HPRT) − Ct(test gene), where
Ct represents the cycle number at the threshold 0.06.
BBM vesicles preparation
NH4Cl-treated WT and KO mice were anesthetized with
ketamine–xylazine intraperitoneally, and kidneys were
removed and rapidly frozen in liquid nitrogen. Brush
border membranes vesicles (BBMV) were prepared as
described previously using the Mg2+-precipitation tech-
nique [6, 7] and further used for western blotting and
transport studies.
Table 1 Primers and probes used for quantitative real-time PCR
Gene Acc. No. Primers Probe
NaPi-IIa
(Slc34a1)
NM_011392 F: 5′-TGATCACCAGCATTGCCG-3′
(907–924)
5′-CCAGACACAACAGAGGCTTCCACTTCTATGTC-3′
(975–1,006)
R: 5′-GTGTTTGCAAGGCTGCCG-3′
(1,022–1,039)
NaPi-IIc
(Slc34a3)
NM_080854 F: 5′-TAATCTTCGCAGTTCAGGTTGCT-3′
(1,399–1,421)
5′-CCACTTCTTCTTCAACCTGGCTGGCATACT-3′
(1,427–1,456)
R: 5′-CAGTGGAATTGGCAGTCTCAAG-3′
(1,478–1,499)
Pit-1
(Slc20a1)
NM_015747 F: 5′-CGC TGC TTT CTG GTA TTA TGT CTG-3′
(972,995)
5′-TTG TTC GTG CGT TCA TCC TCC GTA AGG-3′
(1,011–1,037)
R: 5′-AGA GGT TGA TTC CGA TTG TGC A-3′
(1,085–1,106)
Pit-2
(Slc20a2)
NM_011394 F: 5′-AGG AGT GCA GTG GAT GGA GC-3′
(813–832)
5′-ATT GTC GCC TCC TGG TTT ATA TCG CCA C-3′
(841–868)
R: 5′-ATT AGT ATG AAC AGC ACG CCG G-3′
(887–908)
HPRT NM_013556 F: 5′TTATCAGACTGAAGAGCTACTGTAAGATC-3′
(442–471)
5′-TGAGAGATCATCTCCACCAATAACTTTTATGTCCC-3′
(481–515)
R: 5′-TTACCAGTGTCAATTATATCTTCAACAATC-3′
(539–568)
All primers and probes were designed using Primer Express software (Applied Biosystems). The nucleotide numbers of the primers and probes
are given in brackets.
Pflugers Arch - Eur J Physiol (2008) 457:539–549 541
Transport studies
The transport rate of phosphate into renal BBMV was
determined at 30s and 120min (equilibrium value) as
described [14] at 25°C in the presence of inward gradients
of 100mM NaCl or 100mM KCl and 0.1mM K2HPO4. All
measurements were performed in triplicates.
Western blot analysis
After measurement of the protein concentration (Bio-Rad,
Hercules, CA, USA), 10 μg of brush border membrane
proteins were solubilized in Laemmli sample buffer, (2 %
2-mercaptoethanol), and SDS-PAGE was performed on a
10 % polyacrylamide gel. For immunoblotting, the proteins
were transferred electrophoretically to polyvinylidene fluoride
membranes (Immobilon-P, Millipore, Bedford, MA, USA).
After blocking with 5% milk powder in Tris-buffered saline/
0.1% Tween-20 for 60 min, the blots were incubated with the
primary antibodies: rabbit polyclonal anti-NaPi-IIa (1:6,000)
[10], rabbit affinity-purified anti-NaPi-IIc (1:1,000) raised
against the C-terminal amino acids 588–601 (NH2–
CYENPQVIASQQL–COOH; Pineda Antibody Services,
Berlin, Germany) and mouse monoclonal anti-β-actin
antibody (42kDa; Sigma, St. Louis, MO; 1:5,000) either for
2 h at room temperature or overnight at 4°C. The specificity
of the NaPi-IIc antibody was tested by western blotting and
immunohistochemistry (see supplementary Figs. 1 and 2).
The membranes were then washed three times, blocked for
1 h, and again incubated for 1 h at room temperature with the
secondary goat anti-rabbit or donkey anti-mouse antibodies
1:5,000 linked to alkaline phosphatase (Promega, USA). The
protein signal was detected with the CDP Star chemilumi-
nescence system (Roche Diagnostics, Basel, Switzerland)
using the DIANA III-chemiluminescence detection system
(Raytest, Straubenhardt, Germany). All images were ana-
lyzed using appropriate software (Advanced Image Data
Analyser AIDA, Raytest) to calculate the protein of interest/
β-actin ratio.
Immunohistochemistry
Mouse kidneys were perfusion-fixed through the right
ventricle with a fixative solution, and subsequent immuno-
histochemistry was performed as described previously [11].
Serial cryosections (5 μm) were taken and incubated at 4°C
overnight with a rabbit anti NaPi-IIa 1:1,000 as described
previously [10] or immunopurified rabbit anti NaPi-IIc
1:1,500. The specificity of the immunopurified anti-NaPi-
IIc antibody was characterized as shown in the supplemen-
tary figures (supplementary Fig. 2). Binding sites of the
primary antibodies were detected using Alexa 555-conju-
gated goat/anti-rabbit antibodies (Invitrogen, Basel, Swit-
zerland). F-actin was visualized using fluorescein-coupled
phalloidin (Invitrogen, Basel, Switzerland). Sections were
studied by epifluorescence with a Polyvar microscope
(Reichert Jung, Vienna, Austria), and digital images were
acquired with a charged coupled device camera.
Statistical analysis
Results are expressed as mean ± SEM. All data were tested
for significance using the ANOVA and unpaired Student’s
test where appropriate. Only values with p < 0.05 were
considered as significant.
Results
Induction of metabolic acidosis
NH4Cl-induced metabolic acidosis was achieved after 48h
and 7 days in both WT and NaPi-IIa KO mice, as evident
from the reduction in blood pH and bicarbonate concentra-
tion and the increase in serum chloride concentration
(Table 2). Urinary pH was decreased only in NH4Cl-loaded
WT mice. In NaPi-IIa-deficient animals, urine pH, which
was significantly lower than that of WT mice under control
conditions (5.27 ± 0.07 vs. 6.85 ± 0.30, respectively), was
not changed by NH4Cl treatment (Table 2). Urinary
ammonium excretion was increased in WT and KO acid-
loaded animals. As expected, the plasma phosphate concen-
tration was lower in NaPi-IIa KO mice compared to WT
mice under all conditions examined; however, metabolic
acidosis did not significantly affect blood Pi concentration
either in WT or in KO animals (Table 2). Urinary Pi
excretion was higher in KO mice compared to WT mice
under all conditions examined and was further increased
only in WT animals after 2 days of NH4Cl loading (Table 2;
Fig. 1). In KO animals, acid loading reduced renal phosphate
excretion non-significantly. Metabolic acidosis was more
pronounced in animals receiving NH4Cl for 2 days, as
evident from blood pH and plasma bicarbonate concentra-
tions, indicating partial adaptation of these animals to acid-
base disturbances after 7 days of acid loading (Table 2).
Acidosis alters mRNA expression of renal Na+/phosphate
cotransporters
To investigate the effect of metabolic acidosis on mRNA
expression of renal phosphate transporters, real-time quanti-
tative RT-PCR was performed for NaPi-IIa, NaPi-IIc, Pit1,
and Pit2 and the housekeeping gene HPRT. Induction of
metabolic acidosis with NH4Cl resulted in a decrease in renal
NaPi-IIa mRNA abundance in WT mice after 2 days but not
after 7 days (Fig. 2a). In contrast, a strong decrease in the
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relative mRNA abundance of NaPi-IIc was evident in both
WT and KO mice after 2 and 7 days (Fig. 2b). Under control
conditions, NaPi-IIc mRNA expression was 2-fold higher in
KO mice compared to WT animals. Metabolic acidosis
resulted in increased mRNA expression of Pit1, which
reached significance in WT and KO mice only after 7 days
of acid loading (Fig. 2c). mRNA abundance of Pit2 was not
affected by NH4Cl treatment in WT mice and increased after
7 days of metabolic acidosis in NaPi-IIa KO mice (Fig. 2d).
Metabolic acidosis increases protein expression of renal
Na+/phosphate cotransporters
Western blotting of brush border membranes prepared from
kidneys of control and acid-loaded mice demonstrated that
in contrast to mRNA expression, NH4Cl loading resulted in
a greater abundance of both NaPi-IIa and NaPi-IIc,
immunoreactive protein in WT mice after 2 and 7 days of
treatment (Fig. 3). In NaPi-IIa KO mice expression of
NaPi-IIc was elevated only after 2 days acid loading and
returned to normal values after 7 days (Fig. 3). Effects of
NH4Cl loading on Pit1 and Pit2 protein abundance could
not be investigated due to the lack of specific antibodies
against these two transporters.
Table 2 Summary of blood and urine data from WT and NaPi-IIa KO mice under control conditions and after 2 or 7 days oral acid loading
(0.28M NH4Cl + 2% sucrose in drinking water)
CBL57/6 WT NaPi-IIa KO
Control 2 days acidosis 7 days acidosis Control 2 days acidosis 7 days acidosis
Blood
pH 7.18 ± 0.03 6.99 ± 0.02* 7.12 ± 0.04 7.20 ± 0.03 7.04 ± 0.05* 7.12 ± 0.03
pCO2 (mmHg) 40.7 ± 0.5 34.0 ± 0.9*** 36.7 ± 0.7** 42.3 ± 1.8 39.0 ± 1.8 35.4 ± 2.7
[HCO−3] (mM) 14.0 ± 0.9 8.2 ± 0.3* 11.5 ± 0.9 15.7 ± 1.3 10.5 ± 1.7* 10.9 ± 0.8
[Na+] (mM) 151.2 ± 1.0 150.0 ± 1.1 148.2 ± 1.9 147.8 ± 1.5 156.6 ± 1.8* 158.4 ± 2.8**##
[K+] (mM) 6.8 ± 0.5 7.3 ± 0.4 7.1 ± 0.3 6.6 ± 0.2 7.0 ± 0.5 6.3 ± 0.3
[Cl−] mM 114.8 ± 1.0 128.5 ± 1.4*** 125.6 ± 0.4** 118.6 ± 2.2 128.6 ± 1.9** 143.8 ± 2.7***###
[Pi] (mM) 3.2 ± 0.2 3.1 ± 0.1 3.0 ± 0.2 2.4 ± 0.6# 1.9 ± 0.2# 2.3 ± 0.1#
Urine
pH 6.85 ± 0.30 5.46 ± 0.02*** 5.47 ± 0.02*** 5.27 ± 0.07### 5.39 ± 0.03 5.16 ± 0.03
Creatinine (mg/dl) 25.2 ± 2.3 57.7 ± 2.0** 60.6 ± 3.3*** 47.1 ± 5.0# 50.3 ± 6.6 54.5 ± 7.5
NH3/NH4
+/(mM)/crea (mg/dl) 0.8 ± 0.3 6.3 ± 0.7*** 7.2 ± 0.4*** 1.2 ± 0.7 7.1 ± 1.1*** 6.7 ± 0.8 ***
Na+ (mM)/crea (mg/dl) 2.6 ± 0.2 3.2 ± 0.2 3.0 ± 0.2 1.8 ± 0.2 1.7 ± 0.2### 1.6 ± 0.2###
K+ (mM)/crea (mg/dl) 5.4 ± 0.2 7.4 ± 0.4 6.5 ± 0.3 5.1 ± 0.5 4.2 ± 0.7 ### 4.9 ± 0.4
Ca2+ (mM)/crea (mg/dl) 0.06 ± 0.03 0.12 ± 0.02 0.07 ± 0.01 0.33 ± 0.05## 0.26 ± 0.05 0.29 ± 0.07#
Mg2+ (mM)/crea
(mg/dl)
0.31 ± 0.11 0.71 ± 0.05* 0.68 ± 0.02* 0.76 ± 0.08## 0.57 ± 0.10 0.56 ± 0.06
Cl− (mM)/crea (mg/dl) 3.8 ± 0.3 11.9 ± 0.1*** 13.9 ± 0.9*** 3. ± 0.3 10.3 ± 1.4*** 11.2 ± 1.2***
Pi (mM)/crea (mg/dl) 0.31 ± 0.07 0.61 ± 0.09* 0.34 ± 0.05 1.36 ± 0.06### 1.06 ± 0.10## 1.52 ± 0.16###
24 h Pi (μmol/l) 23.8 ± 3.2 55.2 ± 10.3* 27. ± 4.1 129.2 ± 18.1### 87.7 ± 14.2 93.3 ± 9.3##
Urine volume (ml) 3.4 ± 0.5 1.6 ± 0.1 1.3 ± 0.1 2.1 ± 0.3 1.8 ± 0.4 1.4 ± 0.4
Food intake (mg/g BW) 0.15 ± 0.01 0.11 ± 0.01 0.13 ± 0.01 0.14 ± 0.01 0.07 ± 0.02 0.08 ± 0.0
All data are presented as mean ± SEM, n = 5 per group. *p < 0.05, **p < 0.01, ***p < 0.001; # significantly different between WT and KO (#p <
0.05, ##p < 0.01, ###p < 0.001)
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Fig. 1 Renal phosphate excretion during metabolic acidosis. Urine was
collected over 24 h in metabolic cages from wild-type (Slc34a1+/+)
control mice and mice receiving NH4Cl for 2 or 7 days. Mice deficient
for NaPi-IIa (Slc34a1−/−) were treated in parallel. Acid loading
increased 24 h urinary phosphate excretion in wild-type mice after
2 days, but no effect was observed after 7 days. Slc34a1−/− mice had
higher 24-h phosphate excretion, which was non-significantly reduced
by acid loading for 2 or 7 days (n = 5 animals/group). All data are
presented as mean ± SEM (n = 5). *p < 0.05
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Metabolic acidosis affects brush border membrane Na/Pi
cotransport activity
Sodium-dependent phosphate uptake was increased after
2 days of H4Cl loading in BBMV from wild-type mice with
metabolic acidosis and returned to normal values after
7 days (Fig. 4a). In contrast, in NaPi-IIa-deficient mice,
sodium-dependent phosphate transport was progressively
and significantly decreased in both acid-loaded KO mouse
groups (Fig. 4b).
Metabolic acidosis does not alter distribution of renal
Na+/phosphate cotransporters
Immunohistochemistry was used to determine whether
metabolic acidosis altered segmental and/or subcellular
distribution of renal Na+-dependent phosphate cotransport-
ers NaPi-IIa and NaPi-IIc [20, 26, 30, 32]. Under standard
dietary conditions, NaPi-IIa is expressed in convoluted
(S1 + S2) and straight (S3) proximal tubules of superficial
and juxtamedullary nephrons, whereas the expression of
NaPi-IIc is restricted to the renal cortex in the S1 segment
of deep and superficial proximal tubule (Fig. 5). The
apparent renal distribution of NaPi-IIa and NaPi-IIc was not
changed during metabolic acidosis in WT animals treated
for 2 or 7 days. We also were not able to detect major signal
intensity changes during acid loading in the kidneys of
these animals (Fig. 5a and b). In NaPi-IIa −/− mice, NaPi-
IIc was localized to apical brush border membranes of
proximal S1 segments (Fig. 5c). Furthermore, the signal
intensity of NaPi-IIc staining was stronger in superficial S1
proximal tubules than in wild-type animals (Fig. 5a vs. c).
In addition, few S2 proximal tubules are expressed NaPi-IIc
in NaPi-IIa −/− mice. Acidosis treatment for 2 or 7 days in
these animals did not induce any change in NaPi-IIc signal
intensity or its cortical distribution (Fig. 5c).
Effect of acute metabolic acidosis
We examined the effect of acute metabolic acidosis to
determine whether direct interactions between protons and
the phosphate transporters could reduce renal phosphate
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Fig. 2 Expression of genes encoding renal phosphate transporters.
Real-time RT-PCR was used to assess NaPi-IIa, NaPi-IIc, Pit1, and
Pit2 mRNA levels in kidneys from control and NH4Cl-loaded animals
(n = 5/group). a NaPi-IIa mRNA expression significantly decreased
after 2 days acid loading and returned to normal values after 7 days. b
NaPi-IIc mRNA expression decreased in normal and NaPi-IIa-
deficient mice during MA. Under control conditions, NaPi-IIc
expression was 2-fold higher in NaPi-IIa-deficient mice compared to
wild-type animals. Expression of Pit1 was higher in the absence of
NaPi-IIa and increased in both wild-type and Slc34a1−/−mice only
after 7 days NH4Cl loading (c), whereas Pit2 expression was not
affected by acidosis in wild-type mice but increased after 7 days
NH4Cl loading in NaPi-IIa deficient mice (d). All data are presented
as mean ± SEM (n = 5). *p < 0.05, **p < 0.01, ***p < 0.001
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reabsorption and thereby contribute to phosphaturia. The
induction of acute metabolic acidosis was confirmed by
the presence of lower blood pH and bicarbonate concentra-
tion, lower urine pH, and higher urinary ammonium
excretion. Acute acidosis was also associated with signi-
ficantly elevated urinary phosphate excretion (Table 3,
Fig. 6a). However, NaPi-IIa and NaPi-IIc protein abun-
dance in the brush border membrane fraction remained
unchanged (Fig. 6b).
Discussion
Metabolic acidosis is associated with and causes increased
renal acid elimination that requires adaptive changes in
metabolic and transport pathways. Phosphate, working as a
buffer in blood and as titratable acid in urine, greatly
contributes to increased renal acid secretion [18], and its
excretion into urine is elevated during MA. Previous
transcriptome analysis of kidneys from acid-loaded mice
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Fig. 3 Expression of NaPi-IIa and NaPi-IIc proteins during acid loading.
a Immunoblotting for the Na+/phosphate cotransporters NaPi-IIa and
NaPi-IIc in brush border membranes from control and acid-loaded mice.
All membranes were reprobed for β-actin. b Bar graphs summarizing
data from immunoblotting. All data were normalized against β-actin,
mean ± SEM (n = 5). Protein abundance of NaPi-IIa and NaPi-IIc was
higher in wild-type mice after acid loading for 2 and 7 days. c In NaPi-
IIa-deficient mice, NaPi-IIc expression increased only after 2 days
NH4Cl loading and normalized after 7 days. d Relative NaPi-Iic
expression data in Slc34a3−/− mice. All data were normalized against β-
actin, mean ± SEM (n = 5). *p < 0.05, **p < 0.01
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Fig. 4 BBM sodium-dependent phosphate (Na/Pi) transport activity
in wild-type and NaPi-IIa-deficient mice. Na/Pi cotransport was
determined by sodium-dependent 32P-uptake in BBMV. a NH4Cl
loading reduced Na/Pi transport activity in BBMV from normal mice
after 2 days but not after 7 days. b In NaPi-IIa-deficient mice, MA
resulted in a significant decrease in Na/Pi cotransport activity after 2
and 7 days. n=5 per group. *p<0.05, **p<0.01, ***p<0.001
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revealed a robust downregulation of the type IIc Na+/Pi
cotransporter NaPi-IIc mRNA [25], suggesting that it may
be responsible for the phosphaturia observed.
In the present study, we analyzed the regulation of all
known renal sodium-dependent phosphate cotransporters,
namely, the type II NaPi-IIa and NaPi-IIc and the type III
Pit1 and Pit2. NaPi-IIa-deficient mice served as an
additional tool to distinguish between type IIa-dependent
and IIa-independent transport activities in vivo and ex vivo
and to test the contribution of renal mechanisms to acidosis-
induced phosphaturia. Our findings demonstrate that during
NH4Cl-induced metabolic acidosis in mouse, (1) phospha-
turia is only transient in wild-type mice and no acid-
induced phosphaturia was observed in NaPi-IIa-deficient
mice, (2) sodium-dependent phosphate transport activity is
transiently increased in BBMV from wild-type mice and
decreased in BBMV from NaPi-IIa deficient mice, (3)
NaPi-IIa and NaPi-IIc protein are upregulated in wild-type
mice and NaPi-IIc protein in KO mice, (4) NaPi-IIc mRNA
is strongly reduced, (5) renal localization of NaPi-IIa and
Control 2d Acidosis 7d AcidosisNaPi-IIc
c
NaPi-IIa Control 2d Acidosis 7d Acidosis
Control 2d Acidosis 7d AcidosisNaPi-IIc
a
b
Fig. 5 Immunolocalization of type II Na/Pi cotransporters in kidneys
from wild-type and NaPi-IIa-deficient mice after 2 and 7 days acid
loading. NaPi-IIa (a) or NaPi-IIc (b and c) stainings on renal cortical
overviews and single S1 proximal tubules (higher magnification) from
wild-type (a and b) and NaPi-IIa-deficient mice (c) during acid
loading. No difference in the localization of either NaPi-IIa or NaPi-
IIc were detected in WT and NaPi-IIa-deficient mice after 2 and 7 days
of acid loading
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NaPi-IIc is not affected, (6) phosphaturia in mice following
induction of acute metabolic acidosis was not associated
with changes in the abundance of the type IIa and IIc
phosphate cotransporters in the brush border membrane,
and (7) Pit1 and Pit2 mRNA are increased after 7 days.
Phosphaturia during metabolic acidosis has been attrib-
uted mainly to the release of phosphate from bone and
subsequent renal excretion [17]. However, several causes
may underlie phosphaturia independent from renal phos-
phate transporter protein abundance. The present demon-
stration that acidosis-induced phosphaturia is not observed
in NaPi-IIa-deficient mice may suggest that phosphaturia in
normal mice can be ascribed to decreased renal phosphate
reabsorption via NaPi-IIa rather than originating from bone
release. However, NaPi-IIa is also expressed in osteoclasts
[13], and it has been suggested that NaPi-IIa-deficient
osteoclasts are less active in bone resorption, which may
also contribute to the reduced phosphaturia in acid-loaded
KO mice. A third mechanism that may also contribute to
the acidosis-induced phosphaturia is the direct interaction
of protons with the phosphate transporter(s) in the brush
border membrane of the proximal tubule. Amstutz et al.
have demonstrated in rat isolated brush border membrane
vesicles that a reduction in extracellular pH causes a
decrease in sodium-dependent phosphate transport [2].
The function of the cloned and heterologously expressed
type NaPi-IIa cotransporter is decreased by increasing
extracellular proton concentrations, which interfere at
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Fig. 6 Effects of acute metabolic acidosis. a Urinary phosphate
excretion was increased during acute metabolic acidosis. b Western
blotting for NaPi-IIa and NaPi-IIc abundance in brush border
membranes from control and acidotic mice. All membranes were
reprobed for β-actin. c Quantification of NaPi-IIa/β-actin and NaPi-IIc/
β-actin ratios, n=5 for each group. All data are presented as mean ±
SEM (n=5). **p<0.01
Table 3 Summary of selected urine and blood values from mice
receiving standard chow or NH4Cl in food over a period of 6 hours
Control NH4Cl in food
Blood
pH 7.18 ± 0.01 6.97 ± 0.05**
[HCO−3] (mM) 24.6 ± 1.0 13.4 ± 0.9 ***
[Pi] (mM) 2.60 ± 0.17 3.24 ± 0.27
Urine
pH 5.95 ± 0.07 5.65 ± 0.03**
Creatinine (mg/dl) 62.8 ± 6.2 31.8 ± 2.5**
NH3/NH4
+/(mM)/crea (mg/dl) 1.4 ± 0.3 5.7 ± 0.3***
Pi (mM)/crea (mg/dl) 1.77 ± 0.16 2.80 ± 0.24**
6h Pi (μmol/l) 36.2 ± 3.9 51.4 ± 6.2*
Urine volume (ml/6h) 0.34 ± 0.04 0.59 ± 0.7*
All data are presented as mean ± SEM, n = 5 per group.
*p < 0.05; **p < 0.01; ***p < 0.001
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multiple stages of the transport cycle [9, 36]. Similarly,
transport activity of mouse NaPi-IIc has been shown to be
decreased by increasing extracellular proton concentrations
from pH 7.5 to pH 6.5 [26]. The finding that acutely
induced metabolic acidosis elicits phosphaturia without
altering the abundance of brush border membrane NaPi-IIa
and NaPi-IIc proteins supports the hypothesis that direct
inhibition of transport activity contributes to the develop-
ment of phosphaturia.
In contrast to the present findings, a previous study
linked metabolic acidosis-induced phosphaturia to de-
creased activity and abundance of the renal Na+/Pi
cotransporter NaPi-IIa in rat kidney [1]. However, a
subsequent study performed both in mouse and rat kidney
could not confirm these observations and reported addi-
tionally elevated expression of the intestinal Na+/Pi
cotransporter NaPi-IIb [33]. Our data are in good agreement
with the latter study, demonstrating that both transport
activity and NaPi-IIa and NaPi-IIc protein abundance in the
brush border membrane are increased during metabolic
acidosis. Interestingly, mRNA levels of NaPi-IIa are
reduced slightly after 2 days of acidosis, and NaPi-IIc
mRNA expression is strongly decreased during metabolic
acidosis. Similar discrepancies between NaPi-IIa mRNA
expression, protein abundance, and transport activity have
been observed in potassium-depleted rats [37]. There,
changes in BBM lipid composition and fluidity were found
to be linked to altered transport activity [37]. Also.
Tenenhouse and colleagues observed the unexpected down-
regulation of NaPi-IIc mRNA together with elevation of
protein abundance in NaPi-IIa KO mice [34]. Thus, further
investigation is required to delineate the underlying
mechanism for the lack of concordance between cotrans-
porter mRNA and protein abundance. Interestingly, we also
observed the regulation of two additional sodium-dependent
phosphate cotransporters, Pit1 and Pit2, at the mRNA level
following the induction of metabolic acidosis. Pit1 and Pit2
mRNA were elevated after 7 days of metabolic acidosis,
suggesting that both transporters could contribute to renal
phosphate reabsorption. However, the exact localization of
both transporters in kidney is not well studied. In situ
hybridization for Pit1 (previously known as Glvr-1) de-
scribed localization of Pit1 in most mouse kidney structures
[35]. Interestingly, the transport activity of both Pit-1 and
Pit-2 appears to be increased by extracellular acidification
[15, 27].
In summary, we reanalyzed the regulation of renal
sodium-phosphate cotransporters in mouse kidney during
metabolic acidosis. Our data indicate that phosphaturia
during metabolic acidosis cannot be explained by down-
regulation of protein expression of luminal phosphate
cotransporters. In contrast, we found evidence for increased
renal expression of NaPi-IIa and NaPi-IIc proteins and Pit1
and Pit2 mRNAs. Thus, phosphaturia may be induced
rather by direct interactions between protons and phosphate
cotransporters IIa and IIc, thereby reducing transport
activity. The role of skeletal phosphate release and
increased delivery to the kidney may be less important
than previously suggested.
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